Legal & General Group Plc Has $187.52 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Legal & General Group Plc lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 27.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 315,526 shares of the biotechnology company's stock after selling 121,287 shares during the quarter. Legal & General Group Plc owned 0.41% of Axon Enterprise worth $187,523,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Stifel Financial Corp lifted its holdings in shares of Axon Enterprise by 32.8% during the 3rd quarter. Stifel Financial Corp now owns 23,945 shares of the biotechnology company's stock valued at $9,568,000 after purchasing an additional 5,914 shares in the last quarter. Kovitz Investment Group Partners LLC bought a new stake in shares of Axon Enterprise in the third quarter valued at about $328,000. National Bank of Canada FI boosted its position in shares of Axon Enterprise by 34.0% during the third quarter. National Bank of Canada FI now owns 35,100 shares of the biotechnology company's stock worth $14,026,000 after buying an additional 8,900 shares during the period. Orion Portfolio Solutions LLC grew its holdings in shares of Axon Enterprise by 1.3% during the third quarter. Orion Portfolio Solutions LLC now owns 3,134 shares of the biotechnology company's stock worth $1,252,000 after buying an additional 39 shares in the last quarter. Finally, MML Investors Services LLC lifted its stake in Axon Enterprise by 9.5% in the 3rd quarter. MML Investors Services LLC now owns 24,544 shares of the biotechnology company's stock valued at $9,808,000 after acquiring an additional 2,133 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Remove Ads

Insider Buying and Selling at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 6.10% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. Barclays reissued a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Needham & Company LLC reiterated a "buy" rating and set a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $626.45.

Axon Enterprise Stock Performance

Shares of AXON traded up $4.76 during trading hours on Tuesday, hitting $579.59. The company had a trading volume of 119,266 shares, compared to its average volume of 803,412. The business has a fifty day moving average of $564.96 and a 200-day moving average of $562.96. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $44.41 billion, a price-to-earnings ratio of 149.77, a PEG ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.